FDA Grants Clearance to Clinical Trial for NK CellTech’s Non-Genetically Modified Natural Killer Cells
NK010 is reportedly the first Chinese trial of its kind to be approved by the FDA.
August 16, 2026
NK010 is reportedly the first Chinese trial of its kind to be approved by the FDA.